D. E. Shaw & Co., Inc. Novavax Inc Transaction History
D. E. Shaw & Co., Inc.
- $125 Billion
- Q2 2025
A detailed history of D. E. Shaw & Co., Inc. transactions in Novavax Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 267,200 shares of NVAX stock, worth $2.27 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
267,200
Previous 3,260,908
91.81%
Holding current value
$2.27 Million
Previous $20.9 Million
91.95%
% of portfolio
0.0%
Previous 0.02%
Shares
20 transactions
Others Institutions Holding NVAX
# of Institutions
315Shares Held
94.6MCall Options Held
6.29MPut Options Held
10.6M-
Vanguard Group Inc Valley Forge, PA15.4MShares$131 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$100 Million0.0% of portfolio
-
Shah Capital Management11.5MShares$97.6 Million35.13% of portfolio
-
State Street Corp Boston, MA6.82MShares$57.9 Million0.0% of portfolio
-
Coatue Management LLC New York, NY3.84MShares$32.5 Million0.09% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $663M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...